Doxycycline

Overview

Doxycycline (Doxybactin®, Ronaxan®) is a tetracycline-class antimicrobial widely used in dogs and cats for the treatment of a broad range of bacterial and intracellular infections. It is a time-dependent, bacteriostatic antibiotic that inhibits protein synthesis in susceptible organisms.

Compared with other tetracyclines, doxycycline has high oral bioavailability and superior tissue penetration due to its lipid solubility. It distributes well into respiratory secretions, prostatic fluid, and other tissues, making it particularly useful in systemic and difficult-to-reach infections.

Mechanism of Action (MOA): Doxycycline inhibits bacterial protein synthesis by reversibly binding to the 30S ribosomal subunit, preventing the attachment of aminoacyl transfer-RNA and blocking initiation of protein synthesis. It may also alter bacterial cell membrane permeability.

Indications

Doxycycline is used in dogs and cats as a broad-spectrum antimicrobial, particularly effective against intracellular and atypical pathogens. It is commonly selected when coverage against rickettsial, mycoplasmal, or chlamydial organisms is required.

• Bacterial infections: Active against a wide range of organisms, including certain gram-positive and gram-negative bacteria, as well as spirochetes such as Borrelia, Campylobacter, and Helicobacter.
• Rickettsial infections: Considered a first-line treatment for infections caused by rickettsial organisms.
• Mycoplasma infections: Effective against Mycoplasma spp., including hemotropic infections such as Mycoplasma haemofelis in cats.
• Chlamydial infections (cats): Drug of choice for feline chlamydiosis; treatment courses may be prolonged (typically 3–4 weeks).
• Canine heartworm (adjunctive therapy): Used as part of treatment protocols to eliminate the symbiotic bacterium Wolbachia, improving treatment outcomes.

Dosage (Reference)

Dog

In dogs, doxycycline is administered orally as a once-daily, time-dependent antimicrobial. Consistent daily dosing is important to maintain effective therapeutic concentrations.

Cat

In cats, doxycycline is administered orally once daily. Special care is required during administration to prevent esophageal irritation.

Warnings & Precautions

Doxycycline is generally well tolerated in dogs and cats, but its use requires attention to administration technique, patient selection, and long-term safety considerations.

• Hypersensitivity: Contraindicated in animals with known hypersensitivity to doxycycline or other tetracyclines.
• Esophageal injury (cats): Oral administration, especially dry pilling, may cause esophagitis or esophageal stricture. Always follow dosing with food or water to ensure passage to the stomach.
• Hepatic disease: Use with caution in dogs with significant liver dysfunction, as increases in hepatic enzymes have been reported.
• Pregnancy risk: Tetracyclines may affect fetal skeletal development and cause tooth discoloration; use only when benefits outweigh risks, particularly in late pregnancy.
• Superinfection: Long-term use may lead to overgrowth of nonsusceptible bacteria or fungi.
• Photosensitivity: May increase sensitivity to sunlight; limit exposure in animals with light or thin hair coats.
• Renal safety: Unlike other tetracyclines, doxycycline can be used in patients with renal impairment as it does not accumulate significantly.

Drug Interactions

Doxycycline may interact with several medications primarily through effects on gastrointestinal absorption, protein binding, or antimicrobial activity. These interactions may reduce efficacy or alter therapeutic response, so timing of administration and monitoring are important.

• Aluminum, calcium, and magnesium-containing products: These can chelate doxycycline and significantly reduce its absorption; administer doxycycline at least 1–2 hours before or after such products.
• Iron (oral): Oral iron preparations decrease doxycycline absorption; separate administration by at least 2–3 hours.
• Zinc-containing products: Chelation may occur, reducing absorption of doxycycline or the other drug; separate dosing by 1–2 hours.
• Sucralfate: Significantly reduces doxycycline absorption; administer doxycycline at least 2 hours before sucralfate.
• Bismuth subsalicylate: May reduce absorption; give doxycycline at least 1–2 hours before or after administration.
• Kaolin/pectin: May decrease gastrointestinal absorption; separate dosing by 1–2 hours.
• Proton pump inhibitors (e.g., omeprazole): May reduce oral bioavailability of doxycycline.
• Penicillins, cephalosporins, aminoglycosides: As a bacteriostatic drug, doxycycline may interfere with the bactericidal activity of these antibiotics; clinical significance may vary.
• Phenobarbital: May decrease doxycycline half-life and reduce serum concentrations.
• Enrofloxacin: Concurrent use may alter antibacterial activity against certain organisms.
• Warfarin: May enhance anticoagulant effects by reducing prothrombin activity; dose adjustment may be required.
• Vitamin C (ascorbic acid): May reduce doxycycline efficacy.

Side Effects & Overdose

Side Effects

Doxycycline is generally well tolerated in dogs and cats, but adverse effects are most commonly gastrointestinal and may occur more frequently with oral administration.

• Gastrointestinal effects: Vomiting, diarrhea, and anorexia are the most commonly reported adverse effects; administration with food may help reduce these signs.
• Esophagitis and esophageal stricture: Particularly in cats, oral tablets may cause irritation or injury if retained in the esophagus.
• Elevated liver enzymes: Increases in ALT and ALP have been reported in dogs and cats, usually without significant clinical consequences.
• Photosensitivity: Increased sensitivity to sunlight may occur, especially in animals with light-colored or thin coats.

Overdose

Doxycycline is generally well tolerated in mild overdose situations, with most effects related to gastrointestinal irritation. Severe toxicity is uncommon.

• Gastrointestinal signs: Vomiting, diarrhea, and anorexia are the most common signs following overdose.
• Fluid and electrolyte imbalance: May occur secondary to persistent vomiting or diarrhea; supportive care may be required.
• Supportive management: Treatment is primarily symptomatic, including fluid therapy and monitoring of clinical status.
• Rapid IV administration risk: Rapid intravenous administration may cause collapse or cardiac effects; avoid rapid injection.
• Monitoring: Veterinary consultation is recommended in suspected overdose cases.

Key Notes

Practical clinical points that support effective and appropriate use of doxycycline in dogs and cats:

• Excellent tissue penetration: High lipid solubility allows effective distribution into respiratory secretions, prostate, and other tissues, making it useful in systemic and deep-seated infections.
• Intracellular activity: Particularly effective against intracellular pathogens such as rickettsial organisms, Mycoplasma, and Chlamydia.
• Time-dependent antibiotic: Clinical success depends on maintaining consistent plasma concentrations; adherence to dosing interval is important.
• Resistance considerations: Susceptibility to tetracycline does not always predict doxycycline susceptibility; specific testing may be required in resistant infections.
• Feline chlamydiosis: Often requires extended treatment duration (3–4 weeks) for complete resolution.
• Heartworm protocols (dogs): Used to target Wolbachia organisms, improving outcomes when combined with adulticide therapy.